Tuesday, January 26, 2021
HEALTH CARE
SHOP
  • Home
  • Health & Fitness
  • Disease
  • Healthy Diet
  • Yoga
  • Lose Weight
  • Gain Weight
  • Men Health
  • More
    • Pregnant & Baby Care
No Result
View All Result
Health Care
No Result
View All Result
Home Disease

Imbio Partners with Genentech to Develop Imaging Diagnostics for Lung Diseases

Health Care by Health Care
October 6, 2020
in Disease
0
Imbio Partners with Genentech to Develop Imaging Diagnostics for Lung Diseases
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter
Loading......
 


MINNEAPOLIS, Oct. 6, 2020 /PRNewswire/ — Imbio, a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, has partnered with Genentech, a member of the Roche Group, to develop quantitative imaging diagnostics for lung diseases. The multi-year agreement leverages Imbio’s technical, regulatory and commercial expertise to build and deploy medical imaging AI technology for use in research, clinical trials, and clinical practice.

David Hannes, CEO of Imbio commented, “We are excited to partner with Genentech and we look forward to bringing unique solutions to the field of pulmonary imaging together. This collaboration is a great example of Imbio’s strategy to meet the growing interest by medical device and pharmaceutical companies in using imaging biomarkers and imaging AI to facilitate diagnosis of respiratory diseases.”

“Imaging biomarkers have the potential to significantly improve patient diagnosis, selection and understanding of response to therapy,” said James Sabry, M.D., Ph.D., Global Head of Roche Pharma Partnering. “This collaboration, which combines Imbio’s expertise in imaging biomarkers with Genentech’s pulmonary disease expertise, has the potential to enhance drug development and deliver more personalized healthcare.”

Imbio will continue to develop and market its proprietary portfolio of quantitative imaging algorithms for lung and cardiothoracic diseases outside of the partnership.

About Imbio
Imbio is a leader in fully-automated AI image analysis for acute and chronic pulmonary and cardiothoracic conditions. Imbio’s solutions transform the way patients are discovered, diagnosed and treated, enabling physician productivity and more personalized care for patients. Imbio’s solutions are fully automated, regulatory cleared and available through our global partners.  For more information, please visit www.imbio.com.

Logo – https://mma.prnewswire.com/media/345767/Imbio_Logo.jpg

Related Links

http://www.imbio.com

SOURCE Imbio



Source link

 

Tags: DevelopDiagnosticsdiseasesGenentechImagingImbiolungPartners
Advertisement Banner
Previous Post

Remarkable pictures show how Alaskan bears get fat before hibernation

Next Post

What are Macros? Fitness expert explains everything you need to know

Health Care

Health Care

Next Post
What are Macros? Fitness expert explains everything you need to know

What are Macros? Fitness expert explains everything you need to know

Discussion about this post

Categories

  • Disease
  • Gain Weight
  • Health & Fitness
  • Healthy Diet
  • Lose Weight
  • Men Health
  • Pregnant & Baby Care
  • SHOP
  • Uncategorized
  • Yoga
Who Plays Young Kreese on Cobra Kai?

Who Plays Young Kreese on Cobra Kai?

January 26, 2021
Unused COVID Vaccines Going to Non-Priority People, But It’s All Good

Unused COVID Vaccines Going to Non-Priority People, But It’s All Good

January 26, 2021
25 Best Romantic Comedies on Netflix

25 Best Romantic Comedies on Netflix

January 26, 2021

Follow us

Contact Us

  • Privacy & Policy
  • About US
  • Contact Us
  • Terms & conditions
  • DISCLAIMER

© 2020 Silver Shielding

No Result
View All Result
  • Home
  • Health & Fitness
  • Disease
  • Healthy Diet
  • Yoga
  • Lose Weight
  • Gain Weight
  • Men Health
  • More
    • Pregnant & Baby Care

© 2020 Silver Shielding

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy